SARS-CoV-2 Midnight Chemistry V14 Update![Matt Parker]()
Introduction Please note
the wf-artic workflow has now been updated to select the Medaka variant…
April 19, 2023
2 min
#nextflow 46
EPI2ME Labs 23.04-01 Release![Stephen Rudd]()
We are pleased to release a collection of updates and technical improvements to the EPI2ME Labs…
April 06, 2023
1 min
EPI2ME Labs 23.03-01 Release![Stephen Rudd]()
Our Early March bioinformatics release brings new functionality to the wf-human-variation workflow…
March 08, 2023
2 min
An update on our Copy Number Analysis workflow
We have previously shared our standalone workflow for performing copy number analysis. The…
March 08, 2023
1 min
Short Tandem Repeat expansion genotyping in wf-human-variation
Our human variation workflow, wf-human-variation , gives users the ability to call a range of…
March 08, 2023
2 min
EPI2ME Labs 23.02-02 Release![Stephen Rudd]()
Dear Nanopore community, This second bioinformatics release of February includes a new workflow for…
February 22, 2023
1 min
Information
© 2020 - 2024 Oxford Nanopore Technologies plc. All rights reserved. Registered Office: Gosling Building, Edmund Halley Road, Oxford Science Park, OX4 4DQ, UK | Registered No. 05386273 | VAT No 336942382. Oxford Nanopore Technologies, the Wheel icon, EPI2ME, Flongle, GridION, Metrichor, MinION, MinIT, MinKNOW, Plongle, PromethION, SmidgION, Ubik and VolTRAX are registered trademarks of Oxford Nanopore Technologies plc in various countries. Oxford Nanopore Technologies products are not intended for use for health assessment or to diagnose, treat, mitigate, cure, or prevent any disease or condition.